Legal & General Group Portfolio holdings
Legal & General Group Plc, founded in 1836 by six lawyers in London, is a British multinational financial services company headquartered in London, renowned for its leadership in insurance, pensions, and investment management. Managing trillions in assets, the firm operates through key divisions like Legal & General Investment Management (LGIM), one of the UK’s largest asset managers, focusing on index funds, active strategies, and sustainable investing for institutional clients like pension funds. It also provides life insurance, retirement products, and general insurance, serving millions of customers with a strong emphasis on long-term financial security and infrastructure investment, such as affordable housing. With a heritage of stability and a modern push toward ESG (environmental, social, governance) principles, Legal & General remains a cornerstone of the UK financial landscape with a growing global presence.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Microsoft
MSFT
|
+$657M |
| 2 |
Apple
AAPL
|
+$610M |
| 3 |
Amazon
AMZN
|
+$587M |
| 4 |
AstraZeneca
AZN
|
+$319M |
| 5 |
Snowflake
SNOW
|
+$272M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
ALXN
Alexion Pharmaceuticals
ALXN
|
+$323M |
| 2 |
MXIM
Maxim Integrated Products
MXIM
|
+$273M |
| 3 |
WORK
Slack Technologies, Inc.
WORK
|
+$121M |
| 4 |
PFPT
Proofpoint, Inc.
PFPT
|
+$98.6M |
| 5 |
JD.com
JD
|
+$89.3M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 25.03% |
| 2 | Financials | 13.72% |
| 3 | Healthcare | 12.6% |
| 4 | Consumer Discretionary | 10.97% |
| 5 | Communication Services | 9.76% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
FOLD
2026
DELISTED
Amicus Therapeutics
FOLD
| $1.98M | ﹤0.01% |
207,411
+41,452
| +25% | +$424K |
|
2027
Zumiez
ZUMZ
$339M
| $1.97M | ﹤0.01% |
49,626
+5,556
| +13% | +$237K |
|
2028
MGP Ingredients
MGPI
$375M
| $1.97M | ﹤0.01% |
30,302
+1,459
| +5% | +$93.5K |
|
2029
Genesco
GCO
$422M
| $1.96M | ﹤0.01% |
33,986
-12,577
| -27% | -$748K |
|
2030
Standard Motor Products
SMP
$911M
| $1.96M | ﹤0.01% |
44,747
+2,540
| +6% | +$109K |
|
2031
Caleres
CAL
$487M
| $1.95M | ﹤0.01% |
87,740
+7,521
| +9% | +$181K |
|
|
EBIX
2032
DELISTED
Ebix Inc
EBIX
| $1.95M | ﹤0.01% |
72,271
+5,891
| +9% | +$173K |
|
2033
First Merchants
FRME
$2.67B
| $1.94M | ﹤0.01% |
46,429
+10,657
| +30% | +$433K |
|
2034
Riot Platforms
RIOT
$7.76B
| $1.94M | ﹤0.01% |
75,409
+53,581
| +245% | +$1.72M |
|
|
VIVO
2035
DELISTED
Meridian Bioscience Inc
VIVO
| $1.93M | ﹤0.01% |
100,484
+8,346
| +9% | +$166K |
|
2036
Banc of California
BANC
$2.97B
| $1.93M | ﹤0.01% |
104,154
+9,385
| +10% | +$164K |
|
2037
JELD-WEN Holding
JELD
$164M
| $1.93M | ﹤0.01% |
76,950
-1,862
| -2% | -$49.6K |
|
2038
OraSure Technologies
OSUR
$279M
| $1.93M | ﹤0.01% |
170,249
+14,873
| +10% | +$163K |
|
2039
Saratoga Investment
SAR
$322M
| $1.93M | ﹤0.01% |
66,919
-4,553
| -6% | -$126K |
|
2040
WhiteHorse Finance
WHF
$146M
| $1.92M | ﹤0.01% |
126,283
-5,164
| -4% | -$79.8K |
|
|
EFC
2041
Ellington Financial
EFC
$1.71B
| $1.92M | ﹤0.01% |
104,966
+15,280
| +17% | +$280K |
|
2042
Leslie's
LESL
$11M
| $1.92M | ﹤0.01% |
4,662
+1,301
| +39% | +$623K |
|
2043
Organogenesis Holdings
ORGO
$239M
| $1.91M | ﹤0.01% |
134,057
+31,151
| +30% | +$484K |
|
|
APLS
2044
DELISTED
Apellis Pharmaceuticals
APLS
| $1.91M | ﹤0.01% |
57,899
+12,192
| +27% | +$685K |
|
2045
Lucid Motors
LCID
$2.77B
| $1.9M | ﹤0.01% |
+7,499
| New | +$1.74M |
|
|
HNGR
2046
DELISTED
Hanger Inc.
HNGR
| $1.88M | ﹤0.01% |
85,501
+4,291
| +5% | +$99.4K |
|
|
RC
2047
Ready Capital
RC
$308M
| $1.88M | ﹤0.01% |
129,958
+11,103
| +9% | +$168K |
|
2048
WesBanco
WSBC
$4B
| $1.87M | ﹤0.01% |
54,815
+6,544
| +14% | +$217K |
|
2049
Century Aluminum
CENX
$5.07B
| $1.87M | ﹤0.01% |
138,771
+10,767
| +8% | +$135K |
|
2050
Otter Tail
OTTR
$3.94B
| $1.87M | ﹤0.01% |
33,349
+8,204
| +33% | +$435K |
|
Similar funds
Legal & General Group's Q3 2021 Portfolio in Review
As of Q3 2021, Legal & General Group held 3,551 positions worth $308B, up 2.9% from $299B the previous quarter. Its ten largest holdings account for 22% of the portfolio.
Legal & General Group deployed $10.7B of net new capital in Q3 2021, opening 77 new positions and adding to 2,293 existing holdings. Its largest new stake was AstraZeneca: 2,738,007 shares worth $329M.
By sector, the portfolio is most concentrated in Technology at 25% of assets, up from 24% a quarter earlier, followed by Financials and Healthcare.
On the sell side, the largest reduction was JD.com, an estimated $89.3M trimmed.
- Legal & General Group's largest Q3 2021 buy was AstraZeneca: 2,738,007 shares worth $329M.
- Legal & General Group added most to Microsoft in Q3 2021, an estimated $657M increase.
- Legal & General Group's biggest Q3 2021 reduction was JD.com, cutting an estimated $89.3M.
- Legal & General Group fully exited Alexion Pharmaceuticals in Q3 2021, selling an estimated $323M.
- Legal & General Group's ten largest holdings make up 22% of its $308B portfolio in Q3 2021.
- Legal & General Group opened 77 new positions and closed 55 in Q3 2021.
- Legal & General Group's portfolio value rose 2.9% quarter-over-quarter to $308B.
Based on Legal & General Group's 13F filing for Q3 2021, filed 15 Nov 2021.